Lyme disease does not directly cause a true high red blood cell count, but it can produce a falsely elevated reading on routine bloodwork. The bacteria Borrelia burgdorferi does not stimulate red cell production, yet the immune response and dehydration it triggers can shrink plasma volume enough to concentrate the cells already present. More importantly, a genuine erythrocytosis found alongside Lyme-like symptoms usually points to a separate process. In practice, a high red blood cell count should never be attributed to Lyme disease without ruling out dehydration, chronic hypoxia, and a myeloproliferative disorder, because the two conditions coexisting is a coincidence far more often than a cause.
The Direct Answer: Lyme Does Not Raise Red Cell Production
A high red blood cell count (erythrocytosis) means one of two things. Either the body is making too many red cells, or the plasma—the liquid portion of blood—has fallen so the same number of cells looks concentrated. Lyme disease reliably does neither at the bone-marrow level.
Borrelia burgdorferi is a spirochete, a corkscrew-shaped bacterium transmitted by Ixodes ticks. Its targets are skin, joints, the heart, and the nervous system. It has no known pathway that stimulates erythropoietin, the kidney hormone that orders red cell production, and no mechanism that directly proliferates erythroid precursors in bone marrow. In plain terms: the infection attacks tissue, not the red cell factory.
What Lyme does reliably change is the white blood cell and platelet picture, which is where the confusion often begins. A complete blood count (CBC) in early Lyme may show a mildly low white count, a slight left shift, or elevated inflammatory markers. Those findings get skimmed, and a marginal red cell number nearby gets misread as causal.
How Inflammation and Dehydration Shift the Numbers
If Lyme can't raise red cell production, why does a CBC sometimes flag a high count? The answer is hemoconcentration, and it runs through two mechanisms.
The first is dehydration. Fever, sweats, poor oral intake, and vomiting during acute illness shrink plasma volume. A 5 to 10 percent drop in plasma water can push hematocrit up by 2 to 4 percentage points without a single new red cell. That is enough to cross a lab's upper reference limit in a person who was previously mid-range.
The second is inflammation-driven redistribution. Acute infection raises interleukin-6 and other cytokines. These suppress erythropoietin signaling and sequester iron, which is why the classic Lyme pattern, when it appears at all, leans toward a mild anemia rather than erythrocytosis. The counterintuitive point: the inflammatory signature of Lyme biologically pushes red cell counts down, not up.
So a high reading is more likely an artifact of the sample than a product of the infection. Lab thresholds matter here. Most American laboratories set the upper limit of normal hematocrit near 52 percent for men and 47 percent for women, with hemoglobin cutoffs around 17.5 g/dL and 15.5 g/dL respectively. A reading just above those lines after a febrile illness deserves a repeat, not a diagnosis.
Quantified Context: How Often Is Erythrocytosis Actually Explained?
Erythrocytosis is uncommon, and when it is real, the causes are well mapped. The table below sets the realistic probability of each explanation against Lyme disease, using published prevalence ranges.
| Cause of elevated red cell count | Approximate share of true erythrocytosis cases | Typical hemoglobin pattern | Relationship to Lyme |
|---|---|---|---|
| Dehydration / hemoconcentration | 20–30% of apparent cases | Mildly high, corrects with fluids | Indirect, via fever and poor intake |
| Chronic hypoxia (sleep apnea, lung disease, high altitude) | 15–25% | Sustained, elevated EPO | None; common coincidence |
| Smoking-related erythrocytosis | 10–20% | Mildly high, low-normal EPO | None; common coincidence |
| Polycythemia vera (JAK2 mutation) | 5–10% of true cases | Markedly high, low EPO, high platelets | None; needs hematology workup |
| Testosterone therapy or doping | 5–15% | Dose-dependent | None |
| Lyme disease as direct cause | Effectively zero documented cases | No established pattern | No causal pathway |
The numbers reframe the question. Lyme prevalence in high-incidence US counties runs roughly 100 to 500 cases per 100,000 people per year. Erythrocytosis prevalence is in the low tens per 100,000. The overlap of the two is a statistical coincidence long before it is a mechanism.
When a High Count Is Real: The Separate Causes to Rule Out
A genuinely elevated red cell count, confirmed on a repeat fasting sample, needs its own investigation regardless of Lyme status. The causes split into two families.
Primary erythrocytosis is a bone marrow disorder. Polycythemia vera, driven by a JAK2 V617F mutation in more than 95 percent of cases, makes the marrow overproduce red cells and often platelets. It carries a real thrombosis risk and requires hematology management.
Secondary erythrocytosis is the body responding to low oxygen or a hormonal signal. Chronic obstructive pulmonary disease, untreated sleep apnea, congenital heart defects, high-altitude living, heavy smoking, and testosterone supplementation all fit here. These raise erythropoietin because the kidney senses inadequate oxygen delivery.
The distinction matters because the treatments diverge sharply. Polycythemia vera may need phlebotomy and cytoreductive drugs. Secondary erythrocytosis needs the underlying cause fixed, such as a CPAP machine for sleep apnea. Neither responds to antibiotics, which is the strongest practical argument against blaming Lyme.
The Timeline: What Bloodwork Shows Across Lyme Stages
Blood counts in Lyme follow a time course, and knowing it prevents premature conclusions. The table below maps expected CBC changes by stage.
| Stage | Typical timing after tick bite | Expected red cell change | Expected white cell / platelet change |
|---|---|---|---|
| Incubation | 3–30 days | None | None |
| Early localized (erythema migrans) | Days 3–30 | None; possible mild hemoconcentration if febrile | Mildly low white count in a minority |
| Early disseminated | Weeks 2–8 | None; inflammation favors mild anemia | Occasional mild lymphopenia or thrombocytopenia |
| Late Lyme arthritis | Months to years | None; chronic inflammation may lower count | Usually normal |
| Post-treatment | Months after antibiotics | None attributable to Lyme | Normalizes |
| Coincidental finding | Any time | Reflects dehydration or a separate disorder | Unrelated to Lyme |
The pattern is consistent across stages: no erythrocytosis. If a high red cell count appears during any stage, the timeline itself argues for looking elsewhere. A count that rises and falls with fever and fluid intake is hemoconcentration. A count that stays high for months is not Lyme.
Misconceptions and the Testing Trap
Several errors circulate widely, and each one has a correction.
The first misconception is that any abnormal CBC in a Lyme patient is caused by Lyme. Blood counts are noisy. Up to 5 percent of healthy people fall outside a reference range on any single test, and reference ranges are built to capture 95 percent of a population. A single high value is a signal to repeat, not a diagnosis.
The second is the reverse: that a normal CBC rules out Lyme. It does not. Early Lyme is a clinical diagnosis based on the rash and exposure history, and blood counts are frequently normal throughout.
The third, and most consequential, is the lab-testing trap. Some commercial laboratories offer nonspecific "chronic Lyme" panels that flag borderline results and bundle them with routine bloodwork. A patient sees an elevated red cell count on the same report and assumes the two are linked. They are not. Standard two-tier serology, per CDC guidance, is the validated approach, and it says nothing about red cell counts.
In plain terms: the infection and the red cell number live in separate chapters of the same lab report.
What to Actually Do About a High Red Cell Count With Lyme Symptoms
The practical path is to separate the two questions and answer them in order. The steps below are concrete and testable.
- Repeat the CBC fasting and well hydrated, ideally in the morning, to remove hemoconcentration as a variable before drawing conclusions.
- Ask for ferritin, iron studies, and erythropoietin level, which distinguish primary from secondary erythrocytosis.
- Request a JAK2 V617F mutation test if the count stays high on repeat, since polycythemia vera drives more than 95 percent of primary cases.
- Screen for sleep apnea and review smoking status and testosterone use, the most common reversible secondary causes.
- Pursue Lyme testing through standard two-tier serology only if there is a compatible exposure and symptoms, not to explain a red cell count.
- See a hematologist if hemoglobin exceeds 17.5 g/dL in men or 15.5 g/dL in women on two separate samples.
The sequencing matters. Chasing Lyme as the cause of erythrocytosis delays the diagnosis that actually fits, and delays in polycythemia vera carry measurable clot risk. Action on the blood count should proceed in parallel with, not behind, Lyme evaluation.
The red flags below mean the blood count needs urgent attention independent of any Lyme question.
- Hemoglobin above 18.5 g/dL in men or 16.5 g/dL in women
- New headache, blurred vision, or facial flushing with a high count
- A prior blood clot, especially in an unusual site
- An enlarged spleen on exam or imaging
- Platelets simultaneously above 450,000 per microliter
- A high count that persists across three or more samples over months
Limitations: What the Evidence Cannot Yet Say
Honesty about the gaps is part of the answer. The literature contains no large cohort study directly tracking red cell counts through Lyme infection, so the claim that Lyme does not cause erythrocytosis rests on mechanistic absence rather than a head-to-head trial. That is strong evidence, but it is not the same as a randomized observation.
Case reports of unusual blood findings in Lyme exist, and isolated reports of transient erythrocytosis have appeared. These are hypothesis-generating, not established science, and none demonstrates a causal pathway. They should not be used to reassure a patient with a persistently high count, nor to justify attributing one to Lyme.
The threshold numbers also vary by laboratory and altitude. A resident of Denver at 5,280 feet runs a higher normal hematocrit than a resident of Miami, and reference ranges adjust imperfectly. One reconciled rule: dehydration can shift hematocrit by 2 to 4 points and hemoglobin by roughly 1 to 1.5 g/dL, so any value within that band of the cutoff should be rechecked before it is called abnormal.
The bottom line holds across all of it. Lyme disease can make a red cell count look high through fever and dehydration, but it does not make the body produce more red cells. A truly elevated and persistent count belongs to a different diagnosis, and finding that diagnosis is the clinically useful next step.